에 대한 최신 뉴스 Synopsys (NASDAQ:SNPS) 주식

Synopsys

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Earnings

News

Guidance

After-Hours Center

Movers

SNPS

시놉시스(NASDAQ:SNPS)는 수요일(4일) 장 마감 후에 4분기 재무 실적을 발표했다. 이번 분기 실적 보고서 요약은 다음과 같다. 

시놉시스 4분기 실적: 매출·주당순이익 증가, 부진한 전망, &#39;AI 기반 컴퓨팅 혁신 기회&#39;

Equities

Large Cap

Broad U.S. Equity ETFs

Federal Reserve

Markets

Tech

ETFs

AKAM

EXPE

MNST

PANW

TTWO

S&amp;P 500 지수는 금요일 0.4% 상승한 5,344포인트로 마감하여 2일 연속 상승세를 기록했으며, 주 초반의 급락과 높은 변동성으로 생긴 손실을 완전히 만회했다.

S&amp;P 500은 주간 손실을 만회, 나스닥 100은 강세장이 모멘텀을 되찾으며 4주 하락세를 마감

Global

ATEYY

MRVL

NVDA

SMCI

다가오는 엔비디아(NASDAQ:NVDA)의 분기 실적 결과는 이 회사의 관심사일 뿐만 아니라 엔비디아가 더 나은 성과를 낼 때 상승하는 경향이 있는 다른 인공지능(AI) 관련 주식 6종목에도 관심이 있다. 발생한 일 (What Happened): CNBC에 따르면 분석 결과 엔비디아가 예상을 뛰어넘을 때 일반적으로 긍정적인 반응을 보이는 6개의 AI 관련 주식이 확인되었다.

엔비디아의 성공은 이 6종목의 인공지능 관련 주식을 신고점으로 인도할 것

Synopsys Inc

"We have already taken steps to address all concerns raised by the CMA after their Phase 1 investigation. For example, Synopsys previously announced plans to sell its Optical Solutions business to Keysight, subject to the closing of Synopsys' proposed acquisition of Ansys," the company said.

ANSS

Synopsys Responds To UK CMA's Phase 1 Announcement Regarding Ansys Acquisition; Continues To Express Support For The Transaction

<a href="https://www.gov.uk/government/news/cma-could-approve-synopsys-ansys-merger-if-competition-concerns-are-resolved" title="https://www.gov.uk/government/news/cma-could-approve-synopsys-ansys-merger-if-competition-concerns-are-resolved">https://www.gov.uk/government/news/cma-could-approve-synopsys-ansys-merger-if-competition-concerns-are-resolved</a>

UK's CMA Said Could Approve Synopsys / Ansys Merger If Competition Concerns Are Resolved

WIIM

ADBE

ADSK

AGYS

APPN

ASAN

BILL

BTCS

BTDR

BTOG

CDNS

CLSK

CRWD

CWAN

CYBR

DDOG

DOCU

DSGX

ESTC

ETWO

EVCM

EXFY

FICO

FRSH

FTNT

GREE

GRYP

HTCR

HUBS

INTU

KVYO

LMFA

LSPD

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MSFT

NCTY

NICE

NTNX

PATH

PCOR

PRCH

RAMP

RBRK

SDIG

TEAM

TRAK

TZUP

UPLD

Shares of stocks in the broader software sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), an American electronic design automation company, is preparing to divest an Ansys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>) unit, along with one of its own, to secure EU approval for <a href="https://www.benzinga.com/topic/mergers-and-acquisitions">its $35 billion acquisition,</a> according to sources cited by Reuters. Ansys specializes in software development for autonomous vehicle sensor simulations, including lidar, radar, and camera design.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10.png" alt="" class="wp-image-689110" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12035939/newplot-10-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
The European Commission is awaiting feedback from rivals and customers on Synopsys&#8217; proposal.
Also Read: <a href="https://www.benzinga.com/24/12/42446573/similarwebs-product-upgrades-and-daas-expansion-drive-analyst-bullishness" target="_blank" rel="noreferrer noopener">Goldman Sachs Initiates Similarweb Coverage, Product Upgrades Inspire Bullish Take</a>
Responses are due by Dec.16.
Synopsys agreed to sell its optical design tool maker, Optical Solutions Group, to design and emulation company Keysight Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>).
It has now also offered to divest Ansys PowerArtist, including its research, development, distribution, licensing, selling, and marketing. PowerArtist is a tool for analyzing and reducing power to enable power-efficient design.
Synopsys expects the Ansys deal to close in the first half of 2025, Reuters reports.
Synopsys did not offer any behavioral remedies for its business practices, implying no regulatory objection regarding interoperability and product bundling.
In January 2024, Synopsys <a target="_blank" href="https://www.benzinga.com/m-a/24/01/36646413/why-is-ansys-stock-trading-lower-tuesday" rel="noreferrer noopener">agreed to acquire</a> Ansys for $35 billion through $19 billion in cash and $16 billion in debt.
In May, Synopsys <a href="https://www.benzinga.com/news/24/05/38650313/chip-designer-synopsys-sells-its-software-integrity-business-for-2-1b" target="_blank" rel="noreferrer noopener">forged a deal</a> to sell its Software Integrity Group business to Clearlake Capital Group and Francisco Partners for about $2.1 billion.
In October, the UK&#8217;s antitrust watchdog <a href="https://www.benzinga.com/government/24/10/41549838/uk-launches-antitrust-review-of-synopsys-34-billion-ansys-deal-over-growing-concerns" target="_blank" rel="noreferrer noopener">launched an inquiry</a> into the Synopsys-Ansys deal, citing antitrust concerns.
Synopsys held $4.05 billion in cash and equivalents as of <a href="https://www.benzinga.com/pressreleases/24/12/n42326148/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2024" target="_blank" rel="noreferrer noopener">Oct. 31, 2024</a>. It expects first-quarter revenue of $1.435 billion-$1.465 billion, below the consensus estimates of $1.643 billion, and adjusted EPS of $2.77-$2.82 below the forecast of $3.53.
<a href="https://www.benzinga.com/government/24/11/41685490/nvidias-run-ai-acquisition-draws-european-regulatory-scrutiny-on-competition-concerns" target="_blank" rel="noreferrer noopener">Recent mergers, acquisitions, and investments</a> by Big Tech giants have attracted global antitrust scrutiny. The EU is reviewing Nvidia Corp&#8216;s Run:ai deal over possible stifling of competition in the AI space.
The Federal Trade Commission (FTC) is examining investments by Big Tech giants, including Microsoft Corp, Amazon.com Inc and Google parent Alphabet Inc into AI startups.
Price Actions:&nbsp;ANSS stock closed higher by 1.27% at $344.00 at Wednesday. SNPS closed higher by 1.33%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/downgrades/24/12/42446502/e2open-faces-organic-growth-challenges-debt-overhang-goldman-sachs-downgrades-stock" target="_blank" rel="noreferrer noopener">E2open Faces Organic Growth Challenges, Debt Overhang: Goldman Sachs Downgrades Stock</a></li>
</ul>
Photo: Shutterstock

Government

Regulations

Eurozone

Asset Sales

KEYS

Synopsys Proposes Divesting Units, Including Ansys PowerArtist, For $35 Billion EU Deal Approval

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) has outperformed the market over the past 15 years by 11.7% on an annualized basis producing an average annual return of 23.75%. Currently, Synopsys has a market capitalization of $78.66 billion. 
Buying $100 In SNPS: If an investor had bought $100 of SNPS stock 15 years ago, it would be worth $2,478.51 today based on a price of $512.06 for SNPS at the time of writing.
<h3>Synopsys's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733959818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Synopsys 15 Years Ago Would Be Worth Today

Piper Sandler analyst Clarke Jeffries maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Overweight and lowers the price target from $670 to $655.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Synopsys, Lowers Price Target to $655

Wall Street experienced subdued trading on Thursday morning, with major indices remaining near the flatline as investors awaited further confirmation of potential interest rate cuts from the <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42346164/november-jobs-report-preview-will-it-seal-the-deal-for-a-fed-interest-rate-cut">upcoming November jobs report.</a>
The S&amp;P 500 and Nasdaq 100 edged up by 0.1%, extending their record-high levels, while the Dow Jones Industrial Average slipped 0.3%. Small-cap stocks underperformed, with the Russell 2000 declining 0.8%.
Airline stocks emerged as a standout industry, buoyed by American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>), which surged by a staggering 16% after the company raised its quarterly growth forecast on robust travel demand. 
Shares of United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) gained 5%, while Delta Air Lines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) climbed 4.3%. The broader sector, tracked by the U.S. Global Jets ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JETS#NYSE">JETS</a>), advanced 4%, reaching levels unseen since June 2021.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) added more than 3%, touching highs last seen in March 2022 after Bank of America raised its 12-month price target on the stock from $350 to $400, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42344440/teslas-path-to-400-bank-of-america-highlights-ev-ai-growth">citing improving growth prospects.</a>
The U.S. dollar softened by 0.4%, while Treasury yields held steady, with little movement across the curve.
Gold dropped 0.9%, while copper and silver retreated 0.4% and 0.7%, respectively, reflecting broader weakness in metals.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was up 2.4% to trade around $101,000. The leading cryptocurrency briefly touched $103,650 by 10:00 a.m. ET before retreating slightly amid high volatility.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,090.78</td>
<td>0.1%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,497.32</td>
<td>0.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,829.20</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,407.36</td>
<td>-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120224&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.1% up to $608.06.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.3% to $449.43.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) inched 0.1% up to $523.76.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.8% to $239.12.</li>
<li>The&nbsp;Consumer Discretionary Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, rising 1%; the&nbsp;Materials Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) lagged, down 1.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul>
<li>Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) fell over 11% in reaction to the company&#8217;s latest earnings report. </li>
<li>Other stocks reacting to earnings included SentinelOne Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>), down 10.3%, PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>), down 0.7%, Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>), up 12%, Kroeger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>), up 1.3%, and Dollar General Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>), down 3%. </li>
<li>Companies slated to report their earnings after the close are DocuSign Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>), Ulta Beauty Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>), Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>), Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>), Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>), and Hewlett Packard Enterprise Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>). </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42336184/exclusive-bitcoin-crossing-100000-is-a-defining-moment-experts-say">EXCLUSIVE: Bitcoin Crossing $100,000 Is A &#8216;Defining Moment,&#8217; Experts Say</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Mid Cap

Sector ETFs

Commodities

Econ #s

Economics

$BTC

SPDR Dow Jones Industrial Average ETF Trust

FIVE

JETS

LULU

TSLA

TSX:XL

ULTA

VEEV

Select Sector SPDR-Consumer Discretionary

US Stocks Hold Steady, Travel Demand Fuels Airlines, Tesla Reaches 32-Month Highs: What's Driving Markets Thursday?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Guggenheim raised the price target for Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) from $200 to $220. Guggenheim analyst John Difucci maintained a Buy rating. Oracle shares closed at $188.19 on Wednesday. <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays boosted the price target for Columbia Banking System, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) from $29 to $33. Barclays analyst Jared Shaw maintained an Equal-Weight rating. Columbia Banking shares closed at $30.22 on Wednesday. <a href="https://www.benzinga.com/quote/COLB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley boosted Five Below, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) price target from $100 to $120. Morgan Stanley analyst Simeon Gutman Lipacis maintained an Equal-Weight rating. Five Below shares settled at $104.97 on Wednesday. <a href="https://www.benzinga.com/quote/FIVE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc raised Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) price target from $260 to $315. Keybanc analyst Jason Celino maintained an Overweight rating. Atlassian shares closed at $287.50 on Wednesday. <a href="https://www.benzinga.com/quote/TEAM/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities cut American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) price target from $25 to $21. B of A Securities analyst Christopher Nardone maintained a Neutral rating. American Eagle shares closed at $20.54 on Wednesday.  <a href="https://www.benzinga.com/quote/AEO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho boosted Welltower Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) price target from $136 to $141. Mizuho analyst Omotayo Okusanya maintained an Outperform rating on the stock. Welltower shares closed at $133.59 on Wednesday. See how other analysts view this stock.</li>
<li>Mizuho increased the price target for Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) from $26 to $32. Mizuho analyst Ben Chaiken maintained an Outperform rating. Carnival shares settled at $26.78 on Wednesday. <a href="https://www.benzinga.com/quote/CCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stephens &amp; Co. boosted UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) price target from $605 to $675. Stephens &amp; Co. analyst Scott Fidel maintained an Overweight rating. UnitedHealth shares closed at $610.79 on Wednesday. <a href="https://www.benzinga.com/quote/UNH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Rosenblatt increased the price target for Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) from $635 to $660. Rosenblatt analyst Blair Abernethy maintained a Buy rating. Synopsys shares closed at $588.00 on Wednesday. <a href="https://www.benzinga.com/quote/SNPS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities raised Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) price target from $350 to $400. B of A Securities analyst John Murphy maintained a Buy rating. Tesla shares closed at $357.93 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42338437/top-3-industrials-stocks-youll-regret-missing-in-december"> Top 3 Industrials Stocks You&#8217;ll Regret Missing In December</a></li>
</ul>

COLB

ORCL

WELL

Tesla To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% points on Thursday.
Shares of SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/news/earnings/24/12/42327667/whats-going-on-with-sentinelone-stock-after-hours">third-quarter results</a>.
SentinelOne reported third-quarter revenue of $210.65 million, beating the consensus estimate of $209.72 million, according to Benzinga Pro.
Total revenue increased 28% year-over-year. Annualized recurring revenue (ARR) increased 29% to $859.7 million as of Oct. 31. Customers with ARR of $100,000 or more grew 24% to 1,310 in the quarter. The company ended the quarter with $1.1 billion in cash, cash equivalents and investments.
SentinelOne shares dipped 14.7% to $24.45 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>nCino, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) fell 18.7% to $34.50 in pre-market trading after the company reported third-quarter financial results and issued fourth-quarter revenue guidance below estimates.</li>
<li>American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) fell 14.4% to $17.59 in today's pre-market trading after the company reported a year-over-year decrease in third-quarter sales results. Also, the company said it expects a 4% decrease in fourth-quarter total revenue.</li>
<li>ZJK Industrial Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZJK#NASDAQ">ZJK</a>) declined 14.3% to $11.70 in pre-market trading.</li>
<li>KB Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KB#NYSE">KB</a>) dropped 9.3% to $61.00 in pre-market trading.</li>
<li>Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) dipped 8.4% to $538.60 in pre-market trading after the company issued first-quarter guidance below estimates.</li>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) fell 8.1% to $181.04 in pre-market trading after the company announced quarterly financial results.</li>
<li>PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) fell 7% to $105.00 in pre-market trading following third-quarter results.</li>
<li>Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) fell 6.4% to $10.72 in pre-market trading. The FDA granted Mesoblast&#8217;s Revascor Regenerative Medicine Advanced Therapy Designation in children with congenital heart disease.</li>
<li>Rambus Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) fell 3.8% to $56.71 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42332881/dow-settles-above-45000-for-first-time-investor-sentiment-improves-fear-greed-index-in-greed-zone">Dow Settles Above 45,000 For First Time As Salesforce, Marvell Surge: Investor Sentiment Improves, Fear Index In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

AVAV

MESO

NCNO

RMBS

SentinelOne, AeroVironment, PVH And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Baird analyst Joe Vruwink maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Outperform and lowers the price target from $644 to $630.

Baird Maintains Outperform on Synopsys, Lowers Price Target to $630

Synopsys shares are trading lower after the company issued Q1 guidance below estimates.

Rosenblatt analyst Blair Abernethy maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy and raises the price target from $635 to $660.

Rosenblatt Maintains Buy on Synopsys, Raises Price Target to $660

Needham analyst Charles Shi reiterates Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Buy and maintains $640 price target.

Reiteration

Needham Reiterates Buy on Synopsys, Maintains $640 Price Target

U.S. stocks could open on a weak note on Thursday after the <a href="https://www.benzinga.com/24/12/42332881/dow-settles-above-45000-for-first-time-investor-sentiment-improves-fear-greed-index-in-greed-zone">averages closed at a record high on Wednesday</a>. Futures of all three major indices were marginally down on Thursday, pointing to cautious sentiment on Wall Street.
The tentativeness in U.S. futures comes after Federal Reserve chair Jerome Powell tried to downplay expectations of swift rate cuts, citing a strong economy and uncertainty about inflation.
"The labor market is better, and the downside risks appear to be less in the labor market. Growth is definitely stronger than we thought, and inflation is coming [out] a little higher," Powell said during an interview at the New York Times' DealBook Summit on Wednesday.
"So, the good news is that we can afford to be a little more cautious as we try to find neutral."
However, CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a> shows that expectations of a 25-basis-point rate cut in December stand at 74%, up from 66.5% a week ago.
On Thursday, Bitcoin surged past $103,000 for the first time, with the cryptocurrency trading at $102,407 at the time of writing, according to data from <a href="http://pro.benzinga.com">Benzinga Pro. </a>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.10%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.02%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.01%</td>
</tr>
<tr>
<td>R2K</td>
<td>0.06%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.03% to $607.46 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) declined 0.10% to $522.72, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks closed on a positive note on Wednesday, with all three major indices registering healthy gains. The Dow Jones settled above 45,000 for the first time, while the S&amp;P 500 and Nasdaq solidified their gains.
Crude oil prices edged up on Thursday ahead of OPEC+ decision on production.
Treasury yields rose after jobs data revealed private payrolls came in lower than expected.
On the economic data front, U.S. private businesses added 146K workers to their payrolls for the month of November compared to a revised 184K gain in October, versus market estimates of 150K. U.S. factory orders rose by 0.2% from the previous month to $586.7 billion in October. The ISM services PMI fell to 52.1 in November compared to 56 in October and down from market estimates of 55.5.
Most sectors on the S&amp;P 500 closed on a negative note, with energy, materials, and financial stocks recording the biggest losses on Wednesday.
However, consumer discretionary and information technology stocks bucked the overall market trend, closing the session higher.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>1.30%</td>
<td>19,735.12</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.61%</td>
<td>6,086.49</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.69%</td>
<td>45,014.04</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.42%</td>
<td>2,426.56</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Analysts at BlackRock Investment Institute expect American companies to register growth in the upcoming year.
"Currently, across all the scenarios in the outlook, the platform is gravitating towards the US corporate strength scenario, which is another way of calling for US exceptionalism," said BlackRock Investment Institute's chief investment strategist Wei Li at a media roundtable on Wednesday, according <a href="https://finance.yahoo.com/news/blackrock-sees-exceptionalism-powering-us-stocks-higher-in-2025-100025443.html">to</a> Yahoo Finance.
BlackRock strategists are not alone in their bullish outlook on US equities going into 2025.
Wells Fargo strategists also expect a bull run in 2025, giving a target of 7,007 for the S&amp;P 500.
"On balance, we expect the Trump Administration to usher in a macro environment that is increasingly favorable for stocks at a time when the Fed will be slowly reducing rates," said Wells Fargo&#8217;s Christopher Harvey and his team of strategists.
Ryan Detrick, chief market strategist at Carson Group, explained why bears shouldn't bet against equities in December.
"When the S&amp;P 500 was up 20% or more for the year heading into the final month, December has been up nine of the past 10 times," said Detrick in his latest note.
Detrick's analysis shows that big gains in November set equities on a path for a rally in the new year, too.
"Do big monthly gains matter? We'd say yes, as the S&amp;P 500 is up an average of 13.5% a year later and higher nearly 84% of the time after a calendar month gain of more than 5%."
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures</a>
Upcoming Economic Data
Thursday's economic calendar includes the release of initial jobless claims data for November and U.S. trade deficit data for October will be released at 8:30 a.m. ET.
Stocks In Focus:
<ul>
<li>MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) <a href="https://www.benzinga.com/markets/equities/24/12/42333575/microstrategy-shares-rise-813-in-pre-market-as-bitcoin-surpasses-100k-driving-institutional-interest-and-490-gains-this-year">stock surged over 8%</a> in premarket trading on Thursday, while Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) surged over 3% after Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) hit the <a href="https://www.benzinga.com/24/12/42331261/bitcoin-hits-historic-100000-milestone-michael-saylor-gets-ready-for-party">much-awaited $100,000</a> mark for the first time in its history late night on Wednesday.</li>
<li>SentinelOne Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) stock plunged 15% in premarket trading after the company <a href="https://www.benzinga.com/news/earnings/24/12/42327667/whats-going-on-with-sentinelone-stock-after-hours">missed earnings expectations</a>.</li>
<li>Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) stock fell over 7% in premarket after the software provider's guidance missed estimates.</li>
<li>Five Below Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) stock surged over 13% in premarket after the company raised guidance following strong Black Friday sales and a new CEO announcement.</li>
<li>Investors are awaiting earnings results from Dollar General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>), Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>), and Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) today.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures surged in the early New York session, gaining 0.50% to hover around $68.88 per barrel.
The 10-year Treasury note yield edged up to 4.207%.
Major Asian markets ended mixed on Thursday, while European markets were in the green in early trading.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42333041/teslas-bitcoin-holdings-criticized-by-gary-black-calls-them-irrelevant-to-tsla-stock-price-and-urges-focus-on-ev-growth-and-capital-allocation">Gary Black Says Tesla&#8217;s Bitcoin Holdings Not &#8216;Relevant&#8217; To TSLA&#8217;s Stock Price</a></li>
</ul>
Photo courtesy: Wikimedia

Futures

COIN

MSTR

US Stocks Likely To See Tepid Opening As Bitcoin Blasts Through $103,000: Investors Eye Jobless Claims Data While BlackRock Expects 'US Exceptionalism' To Power Earnings In 2025

Synopsys Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) reported fourth-quarter financial results after the market close on Wednesday. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/12/n42326148/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2024">rundown of the report</a>.
<ul>
<li>Q4 Revenue: $1.64 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $1.63 billion</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: $3.40, versus estimates of $3.30</li>
</ul>
&#8220;The&nbsp;fourth quarter&nbsp;was a strong finish to a transformational year for Synopsys. We achieved record financial results while doubling down on our strategy with the sale of our Software Integrity business and the pending acquisition of Ansys,&#8221; said&nbsp;Sassine Ghazi, president and CEO of Synopsys. 
&#8220;Looking ahead, the AI-driven reinvention of compute is accelerating the pace, scale and complexity of technology R&amp;D, which expands our opportunity to solve engineering challenges from silicon to systems.&#8221;
Synopsys said its previously announced acquisition of Ansys is expected to close in the first half of 2025. The company is working cooperatively with the Federal Trade Commission (FTC) to conclude the <a href="https://www.benzinga.com/government/24/10/41549838/uk-launches-antitrust-review-of-synopsys-34-billion-ansys-deal-over-growing-concerns">investigation</a> and the staff&#8217;s review of Synopsys&#8217; proposed remedies.
Outlook: Synopsys expects first-quarter revenue to be in the range of $1.435 billion to $1.465 billion versus estimates of $1.643 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company sees first-quarter adjusted earnings between $2.77 and $2.82 per share versus estimates of $3.53 per share. 
Synopsys noted that its outlook reflects a change in the company&#8217;s fiscal year from a 52/53-week period ending on the Saturday nearest to&nbsp;Oct. 31&nbsp;of each year to&nbsp;Oct. 31&nbsp;of each year. As a result of this change, there will be 10 fewer days in the first half of fiscal year 2025.
&#8220;In 2025, we expect to deliver double-digit revenue growth grounded in pragmatism given continued macro uncertainties and the impact of our fiscal year calendar change,&#8221; said Shelagh Glaser, CFO of Synopsys.
SNPS Price Action: Synopsys shares were down 6.23% in after-hours, trading at $551.37 at the time of publication Wednesday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42327903/chargepoint-stock-rallies-after-q3-results-eps-in-line-revenues-beat">ChargePoint Stock Rallies After Q3 Results: EPS In Line, Revenues Beat</a></li>
</ul>
Photo: Courtesy of Synopsys.

Synopsys Q4 Earnings: Revenue Beat, EPS Beat, Soft Guidance, Expanding Opportunities Powered By 'AI-Driven Reinvention Of Compute'

Synopsys' Acquisition Of Ansys On Track To Close In H1 2025 As Hart-Scott-Rodino Waiting Period Expires And FTC Review Progresses With Proposed Remedies

Synopsys Sees Q1 2025 Revenue $1.435B-$1.465B Vs $1.643B Est.; Adj. EPS $2.77-$2.82 Vs $3.53 Est.

Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) reported quarterly earnings of $3.40 per share which beat the analyst consensus estimate of $3.30 by 3.03 percent. The company reported quarterly sales of $1.64 billion which beat the analyst consensus estimate of $1.63 billion by 0.32 percent. This is a 2.31 percent increase over sales of $1.60 billion the same period last year.

Earnings Beats

Synopsys Q4 2024 Adj EPS $3.40 Beats $3.30 Estimate, Sales $1.64B Beat $1.63B Estimate

Deep-pocketed investors have adopted a bullish approach towards Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SNPS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 26 extraordinary options activities for Synopsys. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 26% bearish. Among these notable options, 5 are puts, totaling $360,135, and 21 are calls, amounting to $956,100.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $360.0 to $660.0 for Synopsys over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Synopsys stands at 242.12, with a total volume reaching 1,694.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Synopsys, situated within the strike price corridor from $360.0 to $660.0, throughout the last 30 days.
<h3>Synopsys Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733337958_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$11.6</td>
<td>$10.6</td>
<td>$11.1</td>
<td>$560.00</td>
<td>$152.0K</td>
<td align="right">248</td>
<td align="right">175</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$23.4</td>
<td>$23.3</td>
<td>$23.4</td>
<td>$580.00</td>
<td>$119.3K</td>
<td align="right">235</td>
<td align="right">86</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$27.0</td>
<td>$26.3</td>
<td>$26.77</td>
<td>$590.00</td>
<td>$98.9K</td>
<td align="right">205</td>
<td align="right">39</td>
</tr>
<tr>
<td>SNPS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$19.6</td>
<td>$18.4</td>
<td>$19.57</td>
<td>$590.00</td>
<td>$95.1K</td>
<td align="right">148</td>
<td align="right">58</td>
</tr>
<tr>
<td>SNPS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$23.7</td>
<td>$23.1</td>
<td>$23.7</td>
<td>$590.00</td>
<td>$94.8K</td>
<td align="right">12</td>
<td align="right">45</td>
</tr>
</tbody>
</table>

<h3>About Synopsys</h3>
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
In light of the recent options history for Synopsys, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Synopsys</h3>
<ul>
<li>Trading volume stands at 646,372, with SNPS's price up by 3.03%, positioned at $587.47.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>What Analysts Are Saying About Synopsys</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $626.6666666666666.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Synopsys, maintaining a target price of $635. 
&#x2A; An analyst from Wells Fargo has revised its rating downward to Equal-Weight, adjusting the price target to $570. 
&#x2A; An analyst from Loop Capital downgraded its action to Buy with a price target of $675. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Synopsys with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

A Closer Look at Synopsys's Options Market Dynamics

Broadcom, Marvell, Analog Devices among JPMorgan's favorite chip stocks for 2025

Hartford Climate Opportunities Fund Q3 2024 Commentary

Synopsys (SNPS) has disclosed a new risk, in the Corporate Activity and Growth category. The potential failure of Synopsys to realize the expected ...

Synopsys Faces Financial Risks Amid Ansys Merger Integration Challenges

Synopsys (SNPS) issued the following statement in response to the U.K. Competition and Markets Authority's recently published Phase 1 findings rega...

Synopsys: Customers express 'overwhelming support' for Ansys deal

UK regulator has concerns about Synopsys, Ansys merger, but deal could be approved

Latest data shows the largest indicative borrow rate increases among liquid option names include: VinFast Auto LTD (VFS) 102.59% +3.02, Direxion Oi...

Largest borrow rate increases among liquid names

J.P. Morgan's top Technology stocks for 2025

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Marvell (MRVL – Research Report), Synopsys (SNPS –...

Analysts Offer Insights on Technology Companies: Marvell (MRVL), Synopsys (SNPS) and Fiserv (FI)

In a report released yesterday, Joseph Quatrochi from Wells Fargo maintained a Hold rating on Synopsys (SNPS – Research Report), with a price targe...

Cautious Outlook: Synopsys' Revenue Plans and Financial Adjustments Lead to Hold Rating

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Synopsys (NASDAQ:<a href="https://investorplace.com/stock-quotes/snps-stock-quote/">SNPS</a>) just reported results for the third quarter of 2024.<ul><li>Synopsys reported earnings per share of $3.43. This was above the analyst estimate for EPS of $3.28.</li><li>The company reported revenue of $1.53 billion.</li><li>This was 0.39% better than the analyst estimate for revenue of $1.52 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div>	
	The post <a href="https://investorplace.com/earning-results/2024/08/snps-stock-earnings-synopsys-for-q3-of-2024/">SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SNPS Stock Earnings: Synopsys Beats EPS, Beats Revenue for Q3 2024

AMZN

ARMK

AVGO

CMPGF

DELL

GOOG

GOOGL

GWRE

HTHIF

HTHIY

KLAC

KSPI

MNDY

RGTI

SBGSF

SBGSY

SIEGY

TARA

WKHS

Press Releases

Synopsys Enters Definitive Agreement with Keysight Technologies For Sale of Optical Solutions Group

Synopsys and TSMC Pave the Path for Trillion-Transistor AI and Multi-Die Chip Design

Clearlake and Francisco Partners Complete Acquisition of Black Duck Software, Formerly Known as Synopsys Software Integrity Group

Synopsys Announces Earnings Release Date For Fourth Quarter and Fiscal Year 2024

Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024

Comments

Synopsys

뉴스

에 대한 최신 뉴스 Synopsys (NASDAQ:SNPS) 주식

목요일, 12월 05, 2024

토요일, 8월 10, 2024

수요일, 5월 22, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌